The FDA Negotiated Contracts Branch supports the Food and Drug Administration’s mission to protect public health by ensuring the safety, efficacy, and reliability of medical products and scientific research infrastructure. Its core focus is on acquiring advanced analytical instrumentation, biotechnology research tools, and specialized laboratory gases to enable cutting-edge regulatory science.
FDA Negotiated Contracts Branch is a government agency with procurement activity across contracts, awards, and contractors. It currently has 2 open contract opportunities.
Spending trends, top contractors, industry breakdown, and recent contract activity.
AI Mission Profile
The FDA Negotiated Contracts Branch supports the Food and Drug Administration’s mission to protect public health by ensuring the safety, efficacy, and reliability of medical products and scientific research infrastructure. Its core focus is on acquiring advanced analytical instrumentation, biotechno...
The FDA Negotiated Contracts Branch supports the Food and Drug Administration’s mission to protect public health by ensuring the safety, efficacy, and reliability of medical products and scientific research infrastructure. Its core focus is on acquiring advanced analytical instrumentation, biotechnology research tools, and specialized laboratory gases to enable cutting-edge regulatory science. Strategic priorities include modernizing laboratory capabilities for drug safety evaluation, enhancing bioassay development through organ-on-a-chip technologies, and maintaining compliance with quality standards for diagnostic and analytical systems. The branch plays a critical role in sustaining the FDA’s scientific rigor by procuring high-resolution mass spectrometers, ion mobility systems, and custom lab equipment essential for detecting contaminants, characterizing biologics, and validating therapeutic candidates.
Procurement activities center on complex scientific instruments and specialized laboratory services, often issued as combined solicitations or sources-sought notices to gather industry input before formal bidding. The branch frequently utilizes “Brand Name or Equal” specifications to ensure compatibility with validated methodologies while allowing for competitive alternatives. Contract structures emphasize technical precision, traceability, and compliance with federal laboratory standards, with a strong preference for vendors capable of supporting long-term calibration, maintenance, and integration of high-end analytical platforms.
The agency primarily targets manufacturers of analytical laboratory instruments and industrial gas suppliers, with significant engagement in biotechnology R&D services. A pronounced preference for Small Business Administration (SBA) set-asides underscores a commitment to fostering innovation among small, specialized vendors. Vendor relationships are built on technical expertise, regulatory familiarity, and the ability to deliver mission-critical equipment under strict quality controls. Non-set-aside procurements often involve highly specific instrumentation where performance benchmarks are non-negotiable.
As a component of the Food and Drug Administration within the Department of Health and Human Services, the FDA Negotiated Contracts Branch operates nationally to support regulatory science across FDA centers. It utilizes negotiated contracting vehicles tailored to complex scientific acquisitions, ensuring alignment with federal procurement regulations while prioritizing technical excellence over cost alone.
Procurement Analytics
Where FDA Negotiated Contracts Branch directs its contract spending, by industry and small-business set-aside program.